SARS-CoV-2 infection versus the body immune defenses : the role of immune responses and mechanism of action of dexamethasone
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:35 |
|---|---|
| Enthalten in: |
Journal of biological regulators and homeostatic agents - 35(2021), 2 vom: 12. März, Seite 783-786 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sadiq, I Z [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
7S5I7G3JQL |
|---|
| Anmerkungen: |
Date Completed 18.05.2021 Date Revised 07.12.2022 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.23812/20-582-L |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM324877056 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM324877056 | ||
| 003 | DE-627 | ||
| 005 | 20231225191239.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.23812/20-582-L |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1082.xml |
| 035 | |a (DE-627)NLM324877056 | ||
| 035 | |a (NLM)33934592 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sadiq, I Z |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a SARS-CoV-2 infection versus the body immune defenses |b the role of immune responses and mechanism of action of dexamethasone |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.05.2021 | ||
| 500 | |a Date Revised 07.12.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a adaptive immune | |
| 650 | 4 | |a dexamethasone | |
| 650 | 4 | |a immunopathology | |
| 650 | 4 | |a innate immune | |
| 650 | 7 | |a Dexamethasone |2 NLM | |
| 650 | 7 | |a 7S5I7G3JQL |2 NLM | |
| 700 | 1 | |a Muhammad, A |e verfasserin |4 aut | |
| 700 | 1 | |a Sadiq Abubakar, F |e verfasserin |4 aut | |
| 700 | 1 | |a Shuaibu, M N |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of biological regulators and homeostatic agents |d 1989 |g 35(2021), 2 vom: 12. März, Seite 783-786 |w (DE-627)NLM012600660 |x 0393-974X |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2021 |g number:2 |g day:12 |g month:03 |g pages:783-786 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.23812/20-582-L |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 35 |j 2021 |e 2 |b 12 |c 03 |h 783-786 | ||